1. Home
  2. NVNO vs VNRX Comparison

NVNO vs VNRX Comparison

Compare NVNO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

N/A

Current Price

$6.98

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

BUY

Current Price

$0.17

Market Cap

7.2M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
NVNO
VNRX
Founded
1987
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
7.2M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
NVNO
VNRX
Price
$6.98
$0.17
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $13.62
AVG Volume (30 Days)
32.7K
★ 1.3M
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.00
EPS
N/A
★ N/A
Revenue
$31,243.00
★ $1,727,384.00
Revenue This Year
N/A
$57.67
Revenue Next Year
N/A
$240.52
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 40.04
52 Week Low
$0.30
$0.13
52 Week High
$13.44
$3.26

Technical Indicators

Market Signals
Indicator
NVNO
VNRX
Relative Strength Index (RSI) 31.88 26.92
Support Level $0.31 $0.15
Resistance Level $11.47 $0.18
Average True Range (ATR) 0.75 0.02
MACD -0.05 0.01
Stochastic Oscillator 6.93 19.34

Price Performance

Historical Comparison
NVNO
VNRX

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: